Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1928 1
1954 1
1964 1
1965 1
1966 1
1968 2
1969 1
1970 3
1971 5
1972 5
1973 4
1974 6
1975 47
1976 77
1977 77
1978 82
1979 85
1980 99
1981 100
1982 111
1983 142
1984 140
1985 182
1986 179
1987 169
1988 154
1989 190
1990 207
1991 211
1992 192
1993 174
1994 199
1995 166
1996 172
1997 154
1998 189
1999 179
2000 169
2001 145
2002 180
2003 156
2004 160
2005 174
2006 205
2007 207
2008 243
2009 243
2010 250
2011 258
2012 240
2013 219
2014 241
2015 259
2016 273
2017 252
2018 257
2019 259
2020 81
Text availability
Article attribute
Article type
Publication date

Search Results

7,694 results
Results by year
Filters applied: Abstract. Clear all
Page 1
[Clinical analysis of 12 cases of mixed connective tissue disease-associated trigeminal neuropathy].
Gao XJ, Li YH, Zhang XW, Chen S, Liu YY. Gao XJ, et al. Zhonghua Yi Xue Za Zhi. 2020 Mar 31;100(12):938-941. doi: 10.3760/cma.j.cn112137-20191113-02471. Zhonghua Yi Xue Za Zhi. 2020. PMID: 32234170 Chinese.
Objective: The aim of present study is to analyze clinical and laboratory features of mixed connective tissue disease (MCTD)-associated trigeminal neuropathy (TN). ...Raynaud phenomenon (12 cases), arthritis (10cases), edema of fingers (9cases), myositis (6 cases), and pulmonary involvement (11cases) were main cinical feature of MCTD-associate TN. ...
Objective: The aim of present study is to analyze clinical and laboratory features of mixed connective tissue disease (MCTD)-associat …
Ischemic ulcers of the toes secondary to Raynaud's phenomenon in a child successfully treated with botulinum toxin.
Quintana Castanedo L, Feito Rodríguez M, Maseda Pedrero R, Chiloeches Fernández C, de Lucas Laguna R. Quintana Castanedo L, et al. Pediatr Dermatol. 2020 Mar 24. doi: 10.1111/pde.14160. Online ahead of print. Pediatr Dermatol. 2020. PMID: 32212180
Raynaud's phenomenon (RP) is an episodic vasospastic response to cold or emotional stress causing color changes and pain. These attacks can lead to digital ischemia, ulcers, and gangrene. ...
Raynaud's phenomenon (RP) is an episodic vasospastic response to cold or emotional stress causing color changes and pain. Thes
A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer.
Kolinsky MP, Rescigno P, Bianchini D, Zafeiriou Z, Mehra N, Mateo J, Michalarea V, Riisnaes R, Crespo M, Figueiredo I, Miranda S, Nava Rodrigues D, Flohr P, Tunariu N, Banerji U, Ruddle R, Sharp A, Welti J, Lambros M, Carreira S, Raynaud FI, Swales KE, Plymate S, Luo J, Tovey H, Porta N, Slade R, Leonard L, Hall E, de Bono JS. Kolinsky MP, et al. Ann Oncol. 2020 Feb 21:S0923-7534(20)36037-3. doi: 10.1016/j.annonc.2020.01.074. Online ahead of print. Ann Oncol. 2020. PMID: 32205016
Magnetar formation through a convective dynamo in protoneutron stars.
Raynaud R, Guilet J, Janka HT, Gastine T. Raynaud R, et al. Sci Adv. 2020 Mar 13;6(11):eaay2732. doi: 10.1126/sciadv.aay2732. eCollection 2020 Mar. Sci Adv. 2020. PMID: 32201719 Free PMC article.
The ecology of heterogeneity: soil bacterial communities and C dynamics.
Nunan N, Schmidt H, Raynaud X. Nunan N, et al. Philos Trans R Soc Lond B Biol Sci. 2020 May 11;375(1798):20190249. doi: 10.1098/rstb.2019.0249. Epub 2020 Mar 23. Philos Trans R Soc Lond B Biol Sci. 2020. PMID: 32200737
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
Rubio-Rivas M, Corbella X, Guillén-Del-Castillo A, Tolosa Vilella C, Colunga Argüelles D, Argibay A, Vargas Hitos JA, Todolí Parra JA, González-Echávarri C, Ortego-Centeno N, Trapiella Martínez L, Rodríguez Carballeira M, Marín Ballvé A, Pla Salas X, Perales Fraile I, Chamorro AJ, Madroñero Vuelta AB, Freire M, Ruiz Muñoz M, González García A, Pons Martín Del Campo I, Sánchez García ME, Bernal Bello D, Espinosa G, García Hernández FJ, Sáez Comet L, Ríos Blanco JJ, Fernández de la Puebla Giménez RÁ, Sánchez Trigo S, Fonollosa Pla V, Simeón Aznar CP; RESCLE investigators, Autoimmune Diseases Study Group (GEAS). Rubio-Rivas M, et al. Autoimmun Rev. 2020 Mar 17:102507. doi: 10.1016/j.autrev.2020.102507. Online ahead of print. Autoimmun Rev. 2020. PMID: 32194200 Review.
The variables in the final model were as follows: age at diagnosis (+2 points > 65 years-old), male gender (+1 point), lcSSc subset (-1 point), mode of onset other than Raynaud's (+1 point), cancer (+1 point) and visceral involvement, such as ILD (+1 point), PAH (+1 point), heart (+1 point) and renal involvement (+2 points). ...
The variables in the final model were as follows: age at diagnosis (+2 points > 65 years-old), male gender (+1 point), lcSSc subset (-1 p …
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.
Agrawal V, Dinh PC Jr, Fung C, Monahan PO, Althouse SK, Norton K, Cary C, Einhorn L, Fossa SD, Adra N, Travis LB. Agrawal V, et al. JNCI Cancer Spectr. 2019 Oct 8;4(2):pkz079. doi: 10.1093/jncics/pkz079. eCollection 2020 Apr. JNCI Cancer Spectr. 2019. PMID: 32190815 Free PMC article.
Multivariable modeling assessed associations of risk factors and treatment with hearing impairment, tinnitus, peripheral neuropathy, and Raynaud phenomenon. Risk for each AHO statistically increased with both increasing chemotherapy burden (P < .0001) and selected modifiable risk factors (P < .05): hypertension (odds ratio [OR] = 2.40) and noise exposure (OR ≥ 2.3) for hearing impairment; noise exposure for tinnitus (OR ≥ 1.69); peripheral vascular disease for neuropathy (OR = 8.72); and current smoking for Raynaud phenomenon (OR = 2.41). ...
Multivariable modeling assessed associations of risk factors and treatment with hearing impairment, tinnitus, peripheral neuropathy, and …
Interstitial Lung Disease in Anti-Synthetase Syndrome.
Kourkouni E, Mitsogiannis G, Simopoulou T, Liaskos C, Katsiari CG, Daniil Z, Gourgoulianis K, Bogdanos DP, Sakkas LI. Kourkouni E, et al. Mediterr J Rheumatol. 2019 Sep 30;30(3):186-189. doi: 10.31138/mjr.30.3.186. eCollection 2019 Sep. Mediterr J Rheumatol. 2019. PMID: 32185363 Free PMC article.
Anti-synthetase syndrome is an autoimmune disorder characterized by the presence of autoantibodies against aminoacyl transfer RNA (tRNA) synthetases, and myositis, interstitial lung disease (ILD), arthritis, fever and Raynaud's phenomenon (RP). ...Chest CT scan revealed features of interstitial lung disease. Due to rapid deterioration of her lung function, she required oxygen support. ...
Anti-synthetase syndrome is an autoimmune disorder characterized by the presence of autoantibodies against aminoacyl transfer RNA (tRNA) syn …
Ultrasound-mediated topical delivery of econazole nitrate with potential for treating Raynaud's phenomenon.
Daftardar S, Bahl D, Boddu SHS, Altorok N, Kahaleh B. Daftardar S, et al. Int J Pharm. 2020 Mar 14;580:119229. doi: 10.1016/j.ijpharm.2020.119229. Online ahead of print. Int J Pharm. 2020. PMID: 32184178
The study aims to assess the ultrasound-assisted econazole nitrate (EN) permeation from topically applied formulations with potential for treating Raynaud's phenomenon. ...In conclusion, the ultrasound-assisted transdermal delivery of F2_HPMC dispersion could be further studied as a new therapy for Raynaud's phenomenon....
The study aims to assess the ultrasound-assisted econazole nitrate (EN) permeation from topically applied formulations with potential for tr …
7,694 results
Jump to page
Feedback